XCSESMSMED
Market cap21mUSD
Dec 23, Last price
5.48DKK
1D
-1.79%
1Q
-19.17%
IPO
5.38%
Name
Scandinavian Medical Solutions A/S
Chart & Performance
P/E
19.48
P/S
0.67
EPS
0.28
Div Yield, %
0.00%
Shrs. gr., 5y
0.15%
Rev. gr., 5y
48.68%
Revenues
227m
+18.56%
Net income
8m
-36.30%
CFO
3m
P
Profile
Scandinavian Medical Solutions A/S deals in medical imaging equipment worldwide. It offers equipment in the categories of CATH lab, CT, linear accelerator, mammography, PET/CT, SPECT/CT, X-ray, ultrasound, MRI, GAMMA/SPECT, C-arm, mobile X-ray, R/F, DEXA, and others, as well as provides CT, MRI, CATH lab, X-ray, MAMMO, PET/CT, and C-arm parts. The company also provides equipment rental and technical services. It serves hospitals, medical clinics, and distributors. The company was incorporated in 2018 and is based in Aalborg, Denmark.
IPO date
Nov 03, 2021
Employees
Domiciled in
DK
Incorporated in
DK
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | |
| Income | ||||||
Revenues | 226,682 18.56% | 191,192 72.98% | 110,530 54.29% | |||
Cost of revenue | 186,559 | 156,463 | 87,850 | |||
Unusual Expense (Income) | ||||||
NOPBT | 40,123 | 34,729 | 22,680 | |||
NOPBT Margin | 17.70% | 18.16% | 20.52% | |||
Operating Taxes | 2,281 | 3,569 | 3,339 | |||
Tax Rate | 5.69% | 10.28% | 14.72% | |||
NOPAT | 37,842 | 31,159 | 19,341 | |||
Net income | 7,787 -36.30% | 12,224 7.49% | 11,373 39.42% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 244 | 67 | 30,000 | |||
BB yield | -0.13% | -0.02% | -24.96% | |||
| Debt | ||||||
Debt current | 25,893 | 10,914 | 106 | |||
Long-term debt | 30,732 | 38,834 | ||||
Deferred revenue | ||||||
Other long-term liabilities | 3,609 | |||||
Net debt | 45,628 | 41,830 | (40,787) | |||
| Cash flow | ||||||
Cash from operating activities | 3,392 | (8,366) | (10,573) | |||
CAPEX | (18,469) | (40,820) | (13,757) | |||
Cash from investing activities | (11,126) | (39,866) | (13,768) | |||
Cash from financing activities | 18,152 | 21,185 | 26,703 | |||
FCF | 44,107 | (48,954) | (18,488) | |||
| Balance | ||||||
Cash | 10,997 | 7,918 | 27,763 | |||
Long term investments | 13,130 | |||||
Excess cash | 35,366 | |||||
Stockholders' equity | 82,483 | 74,451 | 62,186 | |||
Invested Capital | 121,727 | 119,581 | 28,150 | |||
ROIC | 31.36% | 42.18% | 205.69% | |||
ROCE | 32.71% | 29.04% | 35.71% | |||
| EV | ||||||
Common stock shares outstanding | 27,456 | 27,300 | 26,708 | |||
Price | 6.60 -35.92% | 10.30 128.89% | 4.50 | |||
Market cap | 181,210 -35.56% | 281,190 133.96% | 120,186 | |||
EV | 226,838 | 323,020 | 79,399 | |||
EBITDA | 47,385 | 39,184 | 23,289 | |||
EV/EBITDA | 4.79 | 8.24 | 3.41 | |||
Interest | 5,230 | 977 | 254 | |||
Interest/NOPBT | 13.03% | 2.81% | 1.12% | |||